[Serum-lipid reducing principles--possibilities for treatment. 5. Indications for nicotinic acid and nicotinic acid derivatives].
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008297:Male; D009539:Nicotinic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D013272:Stomach Diseases / Q000139:chemically induced; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood
D009539:Nicotinic Acids; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Serumlipidsänkande principer--behandlingsmöjligheter. 5. Indikationer för nikotinsyra och nikotinsyrederivat.